OpenAlex
PricingAboutJobs
Log inGet started
Work

ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway

HTML PDF

Year: 2018
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2018.02.007
Authors: Andrew M. Kidger, James Sipthorp, Simon J. Cook
Institution: Babraham Institute
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: ERK1/2 inhibitor, Ras signaling, RAF inhibitors, MEK inhibitors, acquired drug resistance, negative feedback loop, KRAS amplification, BRAF amplification, covalent inhibitors, combination therapy, cancer drug targets, receptor tyrosine kinase
SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, Astex Pharmaceuticals, Cancer Research UK, Biotechnology and Biological Sciences Research Council
Awards: G2012023987, Signalling mechanisms that determine the rate of ageing, G3061974823, To define the molecular mechanisms that determine cellular and organismal longevity, G4749662589, A systems approach to understanding lipid, Ca2+ and MAPK signalling networks
OpenAlex ID: W2789608969
FWCI: 2.138
Cites: 150
Cited by: 180
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms